Uploaded November 2021 | Updated September 2026, 2 weeks ago

---

In this video I had great fun speaking with Martin Borch Jensen, Chief Scientific Officer at Gordian Biotechnology, a company that have created the first in vivo therapeutic screen to improve drug design for complex diseases of aging. Previously he was a Post-Doc at the Buck Institute for Research on Aging working on the mitochondrial unfolded protein response. In this discussion we chat further about how this screen works and what the company hope to achieve in terms of therapeutics as well as Martin's recent project 'Longevity Impetus Grants' and also his general interests in the field.

TIMESTAMPS:
Introduction - 00:00
Ideas and previous work on aging - 01:30
How to study aging - 10:15
Gordian Biotechnology & gene therapies - 13:00
Aging Therapeutics - 45:00
Longevity Impetus Grants - 49:00
Longevity areas of interest - 1:04:00
Advice - 1:08:00

Find Martin:
Twitter - twitter.com/MartinBJensen
Gordian - https://www.gordian.bio/
Impetus Grants - impetusgrants.org
Personal Website - martinborchjensen.com

Find me on Twitter - twitter.com/EleanorSheekey

I have Patreon - patreon.com/TheSheekeyScienceShow

Icons in intro; "freepik.com/free-photos-vectors/background"Background vector created by freepik - freepik.com